Medication Errors in Obstetrics

Clinics in Perinatology

Volumn 35, Issue 1, 2008, Pages 101-117

  Kfuri, Toni A ^a   Morlock, Laura ^a   Hicks, Rodney W ^b   Shore, Andrew D ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; ANTIDEPRESSANT AGENT; BUPIVACAINE; BUTORPHANOL; CARBOPROST; CEFAZOLIN; CYCLOPHOSPHAMIDE; DOCUSATE SODIUM; DOXYCYCLINE; ESTROGEN; FENTANYL CITRATE; FLUOXETINE; GLIBENCLAMIDE; IODINATED GLYCEROL; ISOTRETINOIN; KETOROLAC; MAGNESIUM SULFATE; MEDROXYPROGESTERONE; METHOTREXATE; NEVIRAPINE; PARACETAMOL; PAROXETINE; PENICILLIN G; PROPOFOL; SIMVASTATIN; TETRACYCLINE; TRIAZOLAM; UNINDEXED DRUG; WARFARIN;

BACTERIAL ENDOCARDITIS; BIRTH RATE; DEPRESSION; DIABETES MELLITUS; DRUG SAFETY; DRUG USE; HEALTH CARE ORGANIZATION; HOSPITAL CARE; HOSPITAL MANAGEMENT; HUMAN; HYPERTENSION; MATERNAL CARE; MEDICAL PRACTICE; MEDICATION ERROR; PERINATOLOGY; PHARMACEUTICAL CARE; PREECLAMPSIA; PREGNANCY; PREMATURE LABOR; PREVALENCE; PRIORITY JOURNAL; REVIEW; STATISTICAL ANALYSIS; VOMITING;

DATABASES, FACTUAL; FEMALE; FETUS; HUMANS; MEDICATION ERRORS; OBSTETRICS AND GYNECOLOGY DEPARTMENT, HOSPITAL; PERINATAL CARE; PREGNANCY; PRENATAL CARE; PRESCRIPTIONS, DRUG; SAFETY;

EID: 39149094635     PISSN: 00955108     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clp.2007.11.015     Document Type: Review

References (42)

1. Hamilton B.E., Martin J.A., and Ventura S.J. Births: preliminary data for 2005. Natl Vital Stat Rep 55 (2006) 1-18
2. Nabukera S., Wingate M.S., Alexander G.R., et al. First-time births among women 30 years and older in the United States: patterns and risk of adverse outcomes. J Reprod Med 51 (2006) 676-682
3. Glover D.D., Amonkar M., Rybeck B.F., et al. Prescription, over-the-counter, and herbal medicine use in a rural, obstetric population. Am J Obstet Gynecol 188 (2003) 1039-1045
4. Food and Drug Administration, Health and Human Services. Requirements on content and format of labeling for human prescription drug and biological products. Final rule. Fed Regist 71 (2006) 3921-3997
5. Lee E., Maneno M.K., Smith L., et al. National patterns of medication use during pregnancy. Pharmacoepidemiol Drug Saf 15 (2006) 537-545
6. Andrade S.E., Raebel M.A., Morse A.N., et al. Use of prescription medications with a potential for fetal harm among pregnant women. Pharmacoepidemiol Drug Saf 15 (2006) 546-554
7. Lo W.Y., and Friedman J.M. Teratogenicity of recently introduced medications in human pregnancy. Obstet Gynecol 100 (2002) 465-473
8. Cooper W.O., Hickson G.B., and Ray W.A. Prescriptions for contraindicated category X drugs in pregnancy among women enrolled in TennCare. Paediatr Perinat Epidemiol 18 (2004) 106-111
9. Riley E.H., Fuentes-Afflick E., Jackson R.A., et al. Correlates of prescription drug use during pregnancy. J Womens Health (Larchmt) 14 (2005) 401-409
10. Honein M.A., Lindstrom J.A., and Kweder S.L. Can we ensure the safe use of known human teratogens? The iPLEDGE test case. Drug Saf 30 (2007) 5-15
11. Hardy J.R., Leaderer B.P., Holford T.R., et al. Safety of medications prescribed before and during early pregnancy in a cohort of 81,975 mothers from the UK general practice research database. Pharmacoepidemiol Drug Saf 15 (2006) 555-564
12. Raebel M.A., Carroll N.M., Kelleher J.A., et al. Randomized trial to improve prescribing safety during pregnancy. J Am Med Inform Assoc 14 (2007) 440-450
13. Werler M.M., Mitchell A.A., Hernandez-Diaz S., et al. Use of over-the-counter medications during pregnancy. Am J Obstet Gynecol 193 (2005) 771-777
14. American College of Obstetricians and Gynecologists. ACOG Committee Opinion: safe use of medication. Number 331, April 2006. Obstet Gynecol 107 (2006) 969-972
15. Ververs T., Kaasenbrood H., Visser G., et al. Prevalence and patterns of antidepressant drug use during pregnancy. Eur J Clin Pharmacol 62 (2006) 863-870
16. Kallen B., and Otterblad Olausson P. Antidepressant drugs during pregnancy and infant congenital heart defect. Reprod Toxicol 21 (2006) 221-222
17. American College of Obstetricians and Gynecologists. ACOG Committee Opinion Number 328: patient safety in the surgical environment. Obstet Gynecol 107 (2006) 429-433
18. Little J.A., Velazquez M.B., and Rayburn W.F. Reported medication errors in obstetric inpatients in 1 hospital. J Reprod Med 48 (2003) 818-820
19. Forster A.J., Fung I., Caughey S., et al. Adverse events detected by clinical surveillance on an obstetric service. Obstet Gynecol 108 (2006) 1073-1083
20. Pocock S.B., and Chen K.T. Inappropriate use of antibiotic prophylaxis to prevent infective endocarditis in obstetric patients. Obstet Gynecol 108 (2006) 280-285
21. Glover D.D., Rybeck B.F., and Tracy T.S. Medication use in a rural gynecologic population: prescription, over-the-counter, and herbal medicines. Am J Obstet Gynecol 190 (2004) 351-357
22. Reedy M.B., McMillion J.S., Engvall W.R., et al. Inadvertent administration of prostaglandin E1 instead of prostaglandin F2 alpha in a patient with uterine atony and hemorrhage. Obstet Gynecol 79 (1992) 890-894
23. Joy S., Poi M., Hughes L., et al. Third-trimester maternal toxicity with nevirapine use in pregnancy. Obstet Gynecol 106 (2005) 1032-1038
24. Fujii Y., and Numazaki M. Dose-range effects of propofol for reducing emetic symptoms during cesarean delivery. Obstet Gynecol 99 (2002) 75-79
25. Simpson K.R. Minimizing risk of magnesium sulfate overdose in obstetrics. MCN Am J Matern Child Nurs 31 (2006) 340
26. Goodman E.J., Haas A.J., and Kantor G.S. Inadvertent administration of magnesium sulfate through the epidural catheter: report and analysis of a drug error. Int J Obstet Anesth 15 (2006) 63-67
27. Bilal N.E., Gedebou M., and Al-Ghamdi S. Endemic nosocomial infections and misuse of antibiotics in a maternity hospital in Saudi Arabia. APMIS 110 (2002) 140-147
28. Benjamin D.M., and Pendrak R.F. Medication errors: an analysis comparing PHICO's closed claims data and PHICO's event reporting trending system (PERTS). J Clin Pharmacol 43 (2003) 754-759
29. National Practitioner Data Bank for Adverse Information on Physicians and Other Health Care Practitioners. Medical malpractice payments reporting requirements-HRSA: notice of proposed rulemaking. Fed Regist 63 (1998) 71255-71257
30. White A.A., Pichert J.W., Bledsoe S.H., et al. Cause and effect analysis of closed claims in obstetrics and gynecology. Obstet Gynecol 105 (2005) 1031-1038
31. Savage S.W., Schneider P.J., and Pedersen C.A. Utility of an online medication-error-reporting system. Am J Health Syst Pharm 62 (2005) 2265-2270
32. National Coordinating Council for Medication Error Reporting and Prevention (NCC MERP). National Coordinating Council for Medication Error Reporting and Prevention (NCC MERP), about medication errors (1996). Available at: www.nccmerp.org. Accessed August 1, 2004.
33. Rao J.N.K., and Scott A.J. On simple adjustments to chi-square tests with survey data. The Annals of Statistics 15 (1987) 385-397
34. Beyea S.C., Kobokovich L.J., Becker S.C., et al. Medication errors in the LDRP. AWHONN Lifelines 8 (2004) 130-140
35. Institute of Medicine. Preventing medication errors: quality chasm series (2006), National Academy Press, Washington, DC
36. Costello J.L., Torowicz D.L., and Yeh T.S. Effects of a pharmacist-led pediatrics medication safety team on medication-error reporting. Am J Health Syst Pharm 64 (2007) 1422-1426
37. Kuperman G.J., Bobb A., Payne T.H., et al. Medication-related clinical decision support in computerized provider order entry systems: a review. J Am Med Inform Assoc 14 (2007) 29-40
38. Grotting J.B. Reducing medication errors at the point of care. Trustee 55 (2002) 21
39. Poon E.G., Cina J.L., Churchill W., et al. Medication dispensing errors and potential adverse drug events before and after implementing bar code technology in the pharmacy. Ann Intern Med 145 (2006) 426-434
40. Skibinski K.A., White B.A., Lin L.I., et al. Effects of technological interventions on the safety of a medication-use system. Am J Health Syst Pharm 64 (2007) 90-96
41. Donyai P., O'Grady K., Jacklin A., et al. The effects of electronic prescribing on the quality of prescribing. Br J Clin Pharmacol 41 4 (2007) 1-7
42. Franklin B.D., O'Grady K., Donyai P., et al. The impact of a closed-loop electronic prescribing and administration system on prescribing errors, administration errors and staff time: a before-and-after study. Qual Saf Health Care 16 (2007) 279-284